To achieve our mission, we rely on funding from the Swiss Confederation, who has continuously been our largest funder for over 25 years (see this evolution). Building on this stable foundation, our independent status, and the excellence of our workforce and network, we have established the institute as a reference for life science data. This has made us a trusted partner and leader in a range of competitive grants, collaborations and services. In our work on and for cutting-edge technologies, our principal investment is in people. Explore the Sankey chart below for detailed insights into how our financial resources are distributed and allocated.

Supported by competitive and governmental funding, investing in human expertise

  1. Powered by the Swiss Confederation

    The largest and most stable funder of SIB is the State Secretariat for Education, Research and Innovation (SERI). This base contribution accounts for 36% of our institute’s income.

  2. A unique funding model to sustain open resources

    The largest part of SERI’s base contribution is devoted to our open resources (58%, CHF 6.8 million). This subsidy  is complemented by many additional funding sources, including competitive grants and contributions from the industry. In addition, most resources are also supported by short-term research funds held at partner institutions

  3. One-third of SIB’s income comes from competitive funds

    In 2023, CHF 10.5 million (33% of SIB’s income) originate from competitive grants, collaborations and services. This amount is up by 7% compared with 2022. SIB’s independent status, the diversity of skills of its employees, and the full professional support they offer, make the institute a desirable partner. This includes innovative projects with the industry (e.g. Innosuisse) and long-term collaborations in European public-private consortia (e.g. Innovative Medicines/Health Initiatives). 

  4. Keeping up with increasing demands

    The loss of 0.2M (0.6% of expenses) is funded by reserves to support additional open resources, in accordance with the investment strategy for e 2021-2024 period.

  5. A centre of excellence that delivers

    Our centre of excellence includes training and bio­informatics services to universities, private companies and hospitals amounting to a total of CHF 8.5 million. It is mostly funded through collaboration and competitive grants - many international.

  6. Lean and effective management & support

    The management and support functions expenses (12%, CHF 4.3 million) cover day-to-day administration, people and culture, finance, communication, legal and IT support. These support teams also contribute to projects in the key pillars, for which the funds are allocated to the relevant activities (e.g. legal expertise for SPHN is allocated to Coordination).

  7. Investing in people at the heart of research

     71% (CHF 24.5 million) of SIB’s expenses are devoted to our people, of which 73% for employees at the SIB Hub and 27% for employees embedded in partner institutions. This reflects our unique and efficient model anchoring open science infrastructure in research.

  8. Bioinformatics: a variety of competences and shared life science data expertise

A sustained support of the federal government

In the years following its launch in 1998 and alongside the growth of activities, SIB has received sustained support from the federal government.